CoChat

Identification of Metastasis-Associated Receptor Tyrosine Kinases in Non–Small Cell Lung Cancer

Müller-Tidow, Carsten, Diederichs, Sven, Bulk, Etmar, Pohle, Thorsten, Steffen, Björn, Schwäble, Joachim, Plewka, Sylvia, Thomas, Michael, Metzger, Ralf, Schneider, Paul M., Brandts, Christian H., Berdel, Wolfgang E., Serve, Hubert · 2005 · Cancer Research
Cited by 139

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Development of distant metastasis after tumor resection is the leading cause of death in early-stage non–small cell lung cancer (NSCLC). Receptor tyrosine kinases (RTK) are involved in tumorigenesis but only few RTKs have been systematically studied in NSCLC. Here, we provide quantitative real-time reverse transcription-PCR expression data of all RTKs (n = 56) in primary tumors of 70 patients with early-stage (I-IIIA) NSCLC. Overall, 33 RTKs were expressed in at least 25% of the patients. Several RTKs were significantly expressed higher in tumors that ultimately metastasized. The hazard risk for metastasis development in stage I/II disease was increased at least 3-fold for tumors with high expression levels of insulin receptor, neurotrophic tyrosine receptor kinase 1, epidermal growth factor receptor, ERBB2, ERBB3, platelet-derived growth factor receptor β, fibroblast growth factor receptor 1, or leukocyte tyrosine kinase. Relative risks were reduced 3-fold by expression of EPHB6 or DKFZ1. Three members of the epidermal growth factor receptor family were associated with a high risk of metastasis, emphasizing the validity of our data. High ERBB3 expression was significantly associated with decreased survival. Taken together, our genome-wide RTK expression map uncovered the previously unknown value of several RTKs as potential markers for prognosis and metastasis prediction in early-stage NSCLC. The identified RTKs represent promising novel candidates for further functional analyses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-3388

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 139

Metadata

Authors
Müller-Tidow, C., Diederichs, S., Bulk, E., Pohle, T., Steffen, B., Schwäble, J., Plewka, S., Thomas, M., Metzger, R., Schneider, P. M., Brandts, C. H., Berdel, W. E., & Serve, H.
Venue
Cancer Research
Published
2005-03-01
Volume
65
Issue
5
Pages
1778-1782
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2124511021
Cited by
139
References
4
FWCI
5.92
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of Metastasis-Associated Receptor Tyrosine Kinases in Non–Small Cell Lung Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-3388
The paper
Müller-Tidow, C., Diederichs, S., Bulk, E., Pohle, T., Steffen, B., Schwäble, J., Plewka, S., Thomas, M., Metzger, R., Schneider, P. M., Brandts, C. H., Berdel, W. E., & Serve, H. (2005). Identification of Metastasis-Associated Receptor Tyrosine Kinases in Non–Small Cell Lung Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-3388

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.